This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States

Schizophrenia, BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Northwestern University
Condition: Schizophrenia, Bipolarity

View study

WithdrawnNCT02792153

Estradiol and Fear Extinction in Eating disorders (AN)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Eating disorders

View study

CompletedNCT04192266

Estrogen and Fear in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: PTSD

View study

CompletedNCT03689543

Estrogen Receptor Beta and Mood

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 45 Years to 65 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression

View study

CompletedNCT00120250

Eszopiclone for Sleep Disturbance and Nightmares in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: PTSD

View study

CompletedNCT01605253

Eszopiclone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Rush University Medical Center
Condition: PTSD

View study

CompletedNCT04315792

Endoxifen for Bipolarity

This study is completed in the United States. It is testing endoxifen for Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Jina Pharmaceuticals Inc.
Condition: Bipolarity

View study

CompletedNCT02285504

Evaluate SAGE-547 in Female people with Severe Postpartum Depression

This study is completed in the United States. It focuses on depression.

In United States

DepressionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: Depression

View study

CompletedNCT00499863

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

In United States

ADHDDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Noven Therapeutics
Condition: ADHD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.